(Q45789895)

16 December 2017

title

Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response (English)

1 reference

16 December 2017

1 reference

10

1 reference

16 December 2017

Tomas Hajek

T Hajek

1

0 references

Aleksandra Suwalska

A Suwalska

8

0 references

Janusz Rybakowski

4

J Rybakowski

1 reference

16 December 2017

M Alda

13

0 references

Michael C O'Donovan

5

C O'Donovan

1 reference

16 December 2017

author name string

M Bauer

2

1 reference

16 December 2017

C Simhandl

3

1 reference

16 December 2017

A Pfennig

6

1 reference

16 December 2017

B König

7

1 reference

16 December 2017

K Yucel

9

1 reference

16 December 2017

L T Young

11

1 reference

16 December 2017

G MacQueen

12

1 reference

16 December 2017

language of work or name

English

0 references

publication date

31 May 2013

1 reference

16 December 2017

published in

Psychological Medicine

1 reference

16 December 2017

volume

44

1 reference

16 December 2017

issue

3

1 reference

16 December 2017

page(s)

507-517

1 reference

16 December 2017

Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Lithium, gray matter, and magnetic resonance imaging signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

A feasibility and tolerability study of lithium in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Lithium treatment and risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Does lithium protect against dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Lithium response across generations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

The effects of lithium and anticonvulsants on brain structure in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Cerebral cortical gray expansion associated with two second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Progressive gray matter loss in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Affective disorders and risk of developing dementia: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

A systematic review of the effects of antipsychotic drugs on brain volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

Lithium-induced increase in human brain grey matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

7 January 2021

Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

7 January 2021

Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

7 January 2021

Does lithium exert an independent antisuicidal effect?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

7 January 2021

Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

7 January 2021

Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

7 January 2021

A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0033291713001165

7 January 2021

10.1017/S0033291713001165

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017